Cargando…

Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis

Bioimpedance spectroscopy (BIS) is routinely used in peritoneal dialysis patients and might aid fluid status assessment in patients with liver cirrhosis, but the effect of ascites volume removal on BIS-readings is unknown. Here we determined changes in BIS-derived parameters and clinical signs of fl...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwaiger, Elisabeth, Simon, Amrei, Wabel, Peter, Schairer, Benjamin, Berner, Carolin, Signorini, Lorenzo, Ernstbrunner, Matthäus, Evstatiev, Rayko, Schwabl, Philipp, Hinterholzer, Georg, Frommlet, Florian, Vychytil, Andreas, Müller, Christian J., Hecking, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028989/
https://www.ncbi.nlm.nih.gov/pubmed/32071351
http://dx.doi.org/10.1038/s41598-020-59817-3
_version_ 1783499077567119360
author Schwaiger, Elisabeth
Simon, Amrei
Wabel, Peter
Schairer, Benjamin
Berner, Carolin
Signorini, Lorenzo
Ernstbrunner, Matthäus
Evstatiev, Rayko
Schwabl, Philipp
Hinterholzer, Georg
Frommlet, Florian
Vychytil, Andreas
Müller, Christian J.
Hecking, Manfred
author_facet Schwaiger, Elisabeth
Simon, Amrei
Wabel, Peter
Schairer, Benjamin
Berner, Carolin
Signorini, Lorenzo
Ernstbrunner, Matthäus
Evstatiev, Rayko
Schwabl, Philipp
Hinterholzer, Georg
Frommlet, Florian
Vychytil, Andreas
Müller, Christian J.
Hecking, Manfred
author_sort Schwaiger, Elisabeth
collection PubMed
description Bioimpedance spectroscopy (BIS) is routinely used in peritoneal dialysis patients and might aid fluid status assessment in patients with liver cirrhosis, but the effect of ascites volume removal on BIS-readings is unknown. Here we determined changes in BIS-derived parameters and clinical signs of fluid overload from before to after abdominal paracentesis. Per our pre-specified sample size calculation, we studied 31 cirrhotic patients, analyzing demographics, labs and clinical parameters along with BIS results. Mean volume of the abdominal paracentesis was 7.8 ± 2.6 L. From pre-to post-paracentesis, extracellular volume (ECV) decreased (20.2 ± 5.2 L to 19.0 ± 4.8 L), total body volume decreased (39.8 ± 9.8 L to 37.8 ± 8.5 L) and adipose tissue mass decreased (38.4 ± 16.0 kg to 29.9 ± 12.9 kg; all p < 0.002). Correlation of BIS-derived parameters from pre to post-paracentesis ranged from R² = 0.26 for body cell mass to R² = 0.99 for ECV. Edema did not correlate with BIS-derived fluid overload (FO ≥ 15% ECV), which occurred in 16 patients (51.6%). In conclusion, BIS-derived information on fluid status did not coincide with clinical judgement. The changes in adipose tissue mass support the BIS-model assumption that fluid in the peritoneal cavity is not detectable, suggesting that ascites (or peritoneal dialysis fluid) mass should be subtracted from adipose tissue if BIS is used in patients with a full peritoneal cavity.
format Online
Article
Text
id pubmed-7028989
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70289892020-02-26 Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis Schwaiger, Elisabeth Simon, Amrei Wabel, Peter Schairer, Benjamin Berner, Carolin Signorini, Lorenzo Ernstbrunner, Matthäus Evstatiev, Rayko Schwabl, Philipp Hinterholzer, Georg Frommlet, Florian Vychytil, Andreas Müller, Christian J. Hecking, Manfred Sci Rep Article Bioimpedance spectroscopy (BIS) is routinely used in peritoneal dialysis patients and might aid fluid status assessment in patients with liver cirrhosis, but the effect of ascites volume removal on BIS-readings is unknown. Here we determined changes in BIS-derived parameters and clinical signs of fluid overload from before to after abdominal paracentesis. Per our pre-specified sample size calculation, we studied 31 cirrhotic patients, analyzing demographics, labs and clinical parameters along with BIS results. Mean volume of the abdominal paracentesis was 7.8 ± 2.6 L. From pre-to post-paracentesis, extracellular volume (ECV) decreased (20.2 ± 5.2 L to 19.0 ± 4.8 L), total body volume decreased (39.8 ± 9.8 L to 37.8 ± 8.5 L) and adipose tissue mass decreased (38.4 ± 16.0 kg to 29.9 ± 12.9 kg; all p < 0.002). Correlation of BIS-derived parameters from pre to post-paracentesis ranged from R² = 0.26 for body cell mass to R² = 0.99 for ECV. Edema did not correlate with BIS-derived fluid overload (FO ≥ 15% ECV), which occurred in 16 patients (51.6%). In conclusion, BIS-derived information on fluid status did not coincide with clinical judgement. The changes in adipose tissue mass support the BIS-model assumption that fluid in the peritoneal cavity is not detectable, suggesting that ascites (or peritoneal dialysis fluid) mass should be subtracted from adipose tissue if BIS is used in patients with a full peritoneal cavity. Nature Publishing Group UK 2020-02-18 /pmc/articles/PMC7028989/ /pubmed/32071351 http://dx.doi.org/10.1038/s41598-020-59817-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Schwaiger, Elisabeth
Simon, Amrei
Wabel, Peter
Schairer, Benjamin
Berner, Carolin
Signorini, Lorenzo
Ernstbrunner, Matthäus
Evstatiev, Rayko
Schwabl, Philipp
Hinterholzer, Georg
Frommlet, Florian
Vychytil, Andreas
Müller, Christian J.
Hecking, Manfred
Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis
title Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis
title_full Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis
title_fullStr Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis
title_full_unstemmed Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis
title_short Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis
title_sort bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: implications for peritoneal dialysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028989/
https://www.ncbi.nlm.nih.gov/pubmed/32071351
http://dx.doi.org/10.1038/s41598-020-59817-3
work_keys_str_mv AT schwaigerelisabeth bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT simonamrei bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT wabelpeter bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT schairerbenjamin bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT bernercarolin bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT signorinilorenzo bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT ernstbrunnermatthaus bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT evstatievrayko bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT schwablphilipp bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT hinterholzergeorg bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT frommletflorian bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT vychytilandreas bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT mullerchristianj bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis
AT heckingmanfred bioimpedancespectroscopyforfluidstatusassessmentinpatientswithdecompensatedlivercirrhosisimplicationsforperitonealdialysis